Returning for a 3rd year, TPD Boston provides an unrivalled opportunity to network with KOLs and pioneers as well as helping you stay ahead of the curve by focusing on optimizing target validation, improving medicinal chemistry and ultimately accelerating the translation of selective, bioavailable and effective protein degraders into clinical trials.

If you are or want to become a player in the protein degradation arena, this is the meeting that you should attend to engage in meaningful discussions with 350+ pharmaceutical, biotech and translational researchers at the forefront of this growing field that will help drive forward your TPD strategies across all proteome targets and therapeutic indications.